US support for waiving COVID-19 vaccine patent rights puts pressure on drugmakers – but what would a waiver actually look like?
- Written by Dalindyebo Shabalala, Associate Professor, University of Dayton
A COVID-19 surge has pushed hospitals in India beyond their capacity. A stadium in New Delhi was being used as a makeshift ward on May 2, 2021.Getty ImagesThe U.S. and Europe are debating waiving patent rights for COVID-19 vaccines, a move that could allow more companies to produce the vaccine around the world. But it’s not as simple as it...